Redirected Primary Human Chimeric Antigen Receptor Natural Killer Cells as an “Off-The-Shelf Immunotherapy” for Improvement in Cancer Treatment
Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2017.00654
Full Text
Open PDFAbstract
Available in full text
Date
June 9, 2017
Authors
Publisher
Frontiers Media SA